Scilex (SCLX) P/B (2021 - 2026)
Scilex (SCLX) P/B from Mar 5, 2021 to Jul 21, 2026. The TTM Scilex (SCLX) P/B is -0.27. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Scilex (SCLX)
| Year | P/B | Change |
|---|---|---|
| 2026 | -0.27 | +3.89% |
| 2025 | -0.26 | -36.60% |
| 2024 | -0.41 | -65.67% |
| 2023 | -1.18 | -97.06% |
| 2022 | -40.15 | -71.19% |
| 2021 | -139.35 | N/A |
Comparison Scilex (SCLX) P/B with competitors
Scilex (SCLX) P/B is -0.27.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -356.07% |
| GRFS | Grifols SA | 0.79 | -395.75% |
| SNY | Sanofi | 1.27 | -575.44% |
| BIIB | Biogen Inc | 1.52 | -668.66% |
| PFE | Pfizer Inc | 1.55 | -679.52% |
| OGN | Organon & Company | 3.93 | -1569.75% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -1631.52% |
| GSK | GSK Plc | 4.37 | -1736.72% |
| BMY | Bristol-Myers Squibb Company | 6.04 | -2361.16% |
| AZN | Astrazeneca plc | 6.20 | -2421.06% |
| MRK | Merck & Co Inc | 6.68 | -2600.75% |
| GILD | Gilead Sciences Inc | 6.94 | -2698.09% |
| NVO | Novo Nordisk | 7.07 | -2746.76% |
| NVS | Novartis AG | 7.60 | -2945.17% |
| JNJ | Johnson & Johnson | 7.64 | -2960.14% |
| NSRX | Nasus Pharma Ltd | 12.90 | -4929.30% |
| MDCX | MDCorp | 15.34 | -5842.75% |
| AMGN | AMGEN Inc | 21.17 | -8025.29% |
| LLY | Lilly(Eli) & Company | 32.94 | -12431.56% |
| ABBV | Abbvie Inc | 50.46 | -18990.42% |